Skip to main content
. 2015 Jul 15;14:273. doi: 10.1186/s12936-015-0795-z

Figure 3.

Figure 3

The suspect Maloxine® sample, having failed semi-quantitative thin-layer chromatography. The manufacturer is wrong to allege that it is the “only single dose treatment of malaria”.